Skip to content

GlaxoSmithKline and Sanofi say their COVID-19 vaccine won’t be ready until late 2021

The companies say early trials showed the vaccine produced an “insufficient” immune response in people older than 60.

Sanofi headquarters, in Paris
Sanofi headquarters, in ParisRead moreThibault Camus / AP
    by Danica Kirka, The Associated Press
    Published